Hoechst Pakistan Limited (HPL)

PHARMACEUTICALSALLSHRKMIALLSHR

4019.42

+0.68%

As of 10-Jul-2026

52 Week RangeCurrent: 4019.42

2925.664889.99

Updated: 10-Jul-2026

1M+0.4%

3M+2.0%

1Y+29.1%

3Y+482.2%

5Y+349.9%

Valuation Snapshot

Review how the market has valued this company across price multiples.

Updated through 08-Jul-2026

P/E

12.54x

P/B

4.32x

P/S

1.24x

EV/Sales

4.66x

EV/EBITDA

23.57x

Showing 33 observations

Annual Ratio Highlights

Metric	2021	2022	2023	2024	2025
EPS	93.93	17.29	37.41	192.56	301.67
DPS	30.00	0.00	30.00	135.00	240.00
BVPS	541.39	521.78	567.53	706.85	850.93
PER	42.57x	231.29x	106.90x	20.77x	13.26x
Div Yield	0.75%	0.00%	0.75%	3.38%	6.00%
PBV	7.39	7.66	7.05	5.66	4.70
EV/Sales	2.39x	2.10x	1.76x	1.47x	1.22x
Price/Sales	2.43x	2.08x	1.80x	1.44x	1.25x
EV/EBITDA	18.83x	21.80x	15.77x	9.09x	6.17x
EV/Gross Profit	9.21x	8.02x	6.79x	4.67x	3.33x

Metric	2021	2022	2023	2024	2025
Gross Margin	25.96%	26.24%	25.86%	31.51%	36.53%
EBITDA Margin	12.69%	9.66%	11.14%	16.20%	19.74%
Operating Margin	10.57%	8.11%	9.66%	15.05%	18.60%
Pretax Margin	9.04%	3.90%	4.29%	13.01%	16.05%
Net Margin	5.70%	0.90%	1.69%	6.94%	9.41%

Metric	2021	2022	2023	2024	2025
ROE	18.53%	3.26%	6.88%	30.23%	38.76%
ROA	10.11%	1.55%	3.25%	15.85%	20.74%
ROTA	18.73%	13.94%	18.60%	34.36%	41.00%
ROCE	31.85%	29.69%	37.74%	57.30%	68.39%